Table 1.
Clinical properties and laboratory findings in the patients with and without non-alcoholic fatty liver diseasea
| NAFLD (+) (n=159) | NAFLD (–) (n=198) | p | |
|---|---|---|---|
| Age (months) | 146.2±37.5 | 137.9±42.4 | 0.052 |
| Female/Male (n, %) | 79/80 (49.7/50.3) | 120/78 (60.6/39.4) | 0.039 |
| BW (kg) | 72±22.6 | 59.8±19.7 | <0.001 |
| Height (cm) | 156 (143–164) | 150 (138–159) | 0.03 |
| BMI (kg/m2) | 29.4 (25.9–33.4) | 25.6 (23.5–28.5) | <0.001 |
| BWH (%) | 158 (140–174) | 142.5 (128–154) | <0.001 |
| Glucose (mg/dL) | 85 (80–91) | 85 (80.7–90) | 0.49 |
| Insulin (uU/mL) | 20.1 (11.9–27.5) | 14.6 (9.3–21) | <0.001 |
| TC (mg/dL) | 175 (139.5–199) | 181 (148–203) | 0.39 |
| TG (mg/dL) | 113 (79–167) | 116 (81–178) | 0.06 |
| LDL-C (mg/dL) | 115 (83–134) | 130 (90–141) | 0.07 |
| HDL-C (mg/dL) | 44 (38–51) | 46 (40–54) | 0.76 |
| non-HDL-C (mg/dL) | 62 (34–78) | 88 (53–96) | <0.001 |
| ALT (U/L) | 24 (16–36) | 18 (14–23) | <0.001 |
| AST (U/L) | 23 (19–34) | 22 (19–25) | 0.01 |
| sT4 (ng/dL) | 1.22 (1.12–1.33) | 1.23 (1.14–1.34) | 0.26 |
| TSH (mIU/mL) | 2.8 (2.1–3.6) | 2.73 (1.93–3.65) | 0.98 |
a: Data with normal distribution are expressed as mean±SD and the data that do not have a normal distribution are expressed as median (25–75th percentile) values. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; BWH: Body weight-for-height; HDL-C: High-density lipoprotein-cholesterol; LDL-C: Low-density lipoprotein-cholesterol; NAFLD: Non-alcoholic fatty liver disease; TG: Triglyceride; fT4: Free t4; TSH: Thyroid-stimulating hormone; BW: Body weight; BMI: Body mass index